The DOI matches its Crossref record.
Negative Glucocorticoid Receptor Response Elements and their Role in Glucocorticoid Action
Abstract
The glucocorticoid receptor (GR) belongs to the steroid hormone receptor subclass of nuclear receptors and controls physiological processes through activation and repression of specific target genes. The ligand-activated receptor dimer activates gene expression by binding to specific DNA sequences (glucocorticoid response element, GRE) in the promoter regions of glucocorticoid-regulated genes. In contrast to the regulation of these classical GREs, the repression of negatively regulated target genes is mediated by negative GREs (nGRE), composite GREs or by transrepression. Due to their broad therapeutic spectrum and superior therapeutic effects glucocorticoids (GCs) are the most effective drugs used for the treatment of acute and chronic inflammatory diseases. Unfortunately, long term systemic therapy with GCs is restricted due to their metabolic side effects. It is assumed that transrepression of transcription factors such as AP-1 and NF-kappa B is the main mechanism by which glucocorticoids mediate their anti-inflammatory activity, whereas the side effects of GCs are mainly mediated by GR-DNA-interaction either by activation or by negative regulation of gene expression. While trans-repression has been characterized in detail, the molecular mechanisms of DNA-dependent cis-repression remain unclear. In this review, we focus on current knowledge about nGRE-mediated target gene repression and the relevance and function of these genes for glucocorticoid action. Negative GREs contribute to the regulation of the hypothalamic-pituitary-adrenal (HPA) axis (POMC and CRH), bone (osteocalcin) and skin (keratins) function, inflammation (IL-1beta), angiogenesis (proliferin) and lactation (prolactin). The discovery of the underlying mechanisms, especially the comparison to positive GREs and trans-repression may help in the future to discover and analyze novel selective GR agonists.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Antiinflammatory Action of Glucocorticoids — New Mechanisms for Old Drugs
Rhen, T., & Cidlowski, J. A. (2005) · New England Journal of Medicine · doi:10.1056/nejmra050541 · Cited by 3,149
Glucocorticoid resistance in inflammatory diseases
Barnes, P. J., & Adcock, I. M. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60326-3 · Cited by 983
How corticosteroids control inflammation: Quintiles Prize Lecture 2005
Barnes, P. J. (2006) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706736 · Cited by 838
Corticosteroid resistance in patients with asthma and chronic obstructive pulmonary disease
Barnes, P. J. (2013) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2012.12.1564 · Cited by 694
Surjit, M., Ganti, K. P., Mukherji, A., Ye, T., Hua, G., Metzger, D., Li, M., & Chambon, P. (2011) · Cell · doi:10.1016/j.cell.2011.03.027 · Cited by 551
Glucocorticosteroids: current and future directions
Barnes, P. J. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.01199.x · Cited by 533
Stress hormones: physiological stress and regulation of metabolism
Kyrou, I., & Tsigos, C. (2009) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2009.08.007 · Cited by 431
Corticosteroid effects on cell signalling
Barnes, P. J. (2006) · European Respiratory Journal · doi:10.1183/09031936.06.00125404 · Cited by 427
Stress, Visceral Obesity, and Metabolic Complications
KYROU, I., CHROUSOS, G. P., & TSIGOS, C. (2006) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1367.008 · Cited by 380
Oakley, R. H., & Cidlowski, J. A. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.r110.179325 · Cited by 373
The taste of heavy metals: Gene regulation by MTF-1
Günther, V., Lindert, U., & Schaffner, W. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2012.01.005 · Cited by 341
Mechanisms and resistance in glucocorticoid control of inflammation
Barnes, P. J. (2010) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2010.02.018 · Cited by 317
Corticosteroids: The drugs to beat
Barnes, P. J. (2006) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2005.12.052 · Cited by 301
Beck, I. M. E., Vanden Berghe, W., Vermeulen, L., Yamamoto, K. R., Haegeman, G., & De Bosscher, K. (2009) · Endocrine Reviews · doi:10.1210/er.2009-0013 · Cited by 298
Vandevyver, S., Dejager, L., Tuckermann, J., & Libert, C. (2013) · Endocrinology · doi:10.1210/en.2012-2045 · Cited by 296
Barnes, P. J. (2010) · Pharmaceuticals · doi:10.3390/ph3030514 · Cited by 277
Maps and legends: the quest for dissociated ligands of the glucocorticoid receptor
Clark, A. R., & Belvisi, M. G. (2012) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2011.12.004 · Cited by 209
“One mechanism involves the interaction of GR with so-called negative GC response elements (nGREs) (Newton, 2000; Dostert & Heinzel, 2004). nGREs differ from the classical, imperfect palindromic GR binding site consensus as first described.”
Inflammation in Parkinson’s disease: role of glucocorticoids
Herrero, M.-T., Estrada, C., Maatouk, L., & Vyas, S. (2015) · Frontiers in Neuroanatomy · doi:10.3389/fnana.2015.00032 · Cited by 175
Kleiman, A., & Tuckermann, J. P. (2007) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2007.05.009 · Cited by 165
“The mechanism of the binding of the GR to negative acting GREs (nGRE) so far identified only in a limited amount of genes, is less well understood, but seems also to require dimerization (Dostert and Heinzel, 2004).”
BackgroundChIP-Enrich: gene set enrichment testing for ChIP-seq data
Welch, R. P., Lee, C., Imbriano, P. M., Patil, S., Weymouth, T. E., Smith, R. A., Scott, L. J., & Sartor, M. A. (2014) · Nucleic Acids Research · doi:10.1093/nar/gku463 · Cited by 151
Silverman, M. N., Mukhopadhyay, P., Belyavskaya, E., Tonelli, L. H., Revenis, B. D., Doran, J. H., Ballard, B. E., Tam, J., Pacher, P., & Sternberg, E. M. (2013) · Molecular Psychiatry · doi:10.1038/mp.2012.131 · Cited by 64
Kamiyama, K., Matsuda, N., Yamamoto, S., Takano, K.-I., Takano, Y., Yamazaki, H., Kageyama, S.-I., Yokoo, H., Nagata, T., Hatakeyama, N., et al. (2008) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00459.2007 · Cited by 53
“Another mechanism of GR action is currently thought to be important for most of the GR anti-inflammatory functions, which is based on the ability of liganded GR monomers to interact directly with other proinflammatory transcription factors, such as NF- B, thereby repressing or potentiating their activity (17).”
Taniguchi, Y., Iwasaki, Y., Tsugita, M., Nishiyama, M., Taguchi, T., Okazaki, M., Nakayama, S., Kambayashi, M., Hashimoto, K., & Terada, Y. (2010) · Endocrinology · doi:10.1210/en.2009-1254 · Cited by 36
Bei, E., Salpeas, V., Pappa, D., Anagnostara, C., Alevizos, V., & Moutsatsou, P. (2009) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2009.03.002 · Cited by 35
“…to glucocorticoid response elements (GREs) onDNA in the promoter of target genes, resulting in stimulation or suppression of the transcription of responsive genes (known as transactivation effect) (Beato et al., 1995; Beato and Sanchez-Pacheco, 1996; Kino et al., 2003; Dostert and Heinzel, 2004).”
Metadata
- Authors
- A., D., & T., H.
- Venue
- Current Pharmaceutical Design
- Publisher
- Bentham Science Publishers Ltd.
- Published
- 2004-09-01
- Volume
- 10
- Issue
- 23
- Pages
- 2807-2816
- ISSN
- 1381-6128 (ISSN-L)
- OpenAlex
- W1979181245
- Cited by
- 225
- References
- 0
- FWCI
- 6.57
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.